Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.3.3 to v3.3.4. No study details or content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:53:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Introduced a new Locations section listing study sites in Florida, Pennsylvania, Tennessee, Virginia, and Wisconsin. The footer will show Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-24T14:54:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Publications are described as auto-filled from PubMed in the Publications section. The revision tag now shows version v3.3.2, replacing the previous v3.2.0 description.
    Difference
    0.1%
    Check dated 2025-11-24T21:09:46.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. Core study details, eligibility criteria, and contacts remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:33:16.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The update appears to include non-substantive changes such as updated Study Record Dates and minor formatting; core study content (interventions, eligibility criteria, endpoints) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:08.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Core content updated: adds a funding-lapse notice with open status for the NIH Clinical Center and directs to status sites; replaces version v3.1.0 with v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:24:19.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.